Increased risk of colon cancer after external radiation therapy for prostate cancer

International Journal of Cancer

Volumn 123, Issue 5, 2008, Pages 1141-1145

  Rapiti, Elisabetta ^a   Fioretta, Gerald ^a   Verkooijen, Helena M ^a,b   Zanetti, Roberto ^c   Schmidlin, Franz ^d,e   Shubert, Hyma ^a   Merglen, Arnaud ^a   Miralbell, Raymond ^d   Bouchardy, Christine ^a  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CPO   (Italy)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e Urological Center   (Switzerland)

Author keywords

Colorectal cancer; Prostate cancer; Radiotherapy; Secondary neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; COLON CANCER; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SWITZERLAND; CANCER STAGING; COLON; COLON TUMOR; INCIDENCE; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; RADIATION INJURY; RADIOTHERAPY; REGISTER; RISK; RISK FACTOR; SECOND CANCER; TIME;

AGED; AGED, 80 AND OVER; COLON; COLONIC NEOPLASMS; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; PROSTATIC NEOPLASMS; RADIOTHERAPY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TIME FACTORS;

EID: 47249129935     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23601     Document Type: Article

References (24)

1. Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995;87:732-41.
2. Boice JD, Jr, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC, Austin DF, Bosch A, Cookfair DL. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988;116:3-55.
3. Kleinerman RA, Curtis RE, Boice JD, Jr, Flannery JT, Fraumeni JF, Jr. Second cancers following radiotherapy for cervical cancer. J Natl Cancer Inst 1982;69:1027-33.
4. Bergfeldt K, Einhorn S, Rosendahl I, Hall P. Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study. Acta Oncol 1995;34:771-7.
5. Bokemeyer C, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 1995;13:283-92.
6. Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004;91:868-72.
7. Pickles T, Phillips N. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Rradiother Ooncol. 2002;65:145-51.
8. Moon K, Stukenborg GJ, Keim J, Theodorescu D. Cancer incidence after localized therapy for prostate cancer. Cancer. 2006;107:991-8.
9. Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology. 2005;128:819-24.
10. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000;88:398-406.
11. Neugut AI, Ahsan H, Robinson E, Ennis RD. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer. 1997;79:1600-4.
12. Movsas B, Hanlon AL, Pinover W, Hanks GE. Is there an increased risk of second primaries following prostate irradiation? Int. J Radiat. Oncol. Biol. Phys. 1998;41:251-5.
13. Kendal WS, Eapen L, Macrae R, Malone S, Nicholas G. Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. Int. J Radiat. Oncol. Biol. Phys. 2006.
14. Bouchardy C. Switzerland, Geneva. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, (eds.). Cancer incidence in five continents., Vol. VIII. Lyon: International Agency for Research on Cancer, 2003:448-9.
15. Percy CL, Van Holten V, Muir C, eds. ICD-O International classification of diseases for oncology, 2nd edition. 2 ed. Geneva: World Health Organization, 1990.
16. World Health Organization (WHO), eds. ICD-O International classification of diseases for oncology. 1st edn. Geneva: World Health Organization, 1976.
17. World Health Organization (WHO), eds. ICD-8. International classification of diseases. 1st edn. Geneva: World Health Organization, 1965.
18. Breslow NE, Day NE. Statistical methods in cancer research. Vol. II: the design and analysis of cohort studies. IARC Scientific Publications no 82. Lyon: International Agency for Research on Cancer, 1987.
19. McMaster ML, Feuer EJ, Tucker MA. New malignancies following cancer of the male genital tract. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF, Jr. (eds.) New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute, 2006:
20. Ryberg M, Lundell M, Nilsson B, Pettersson F. Malignant disease after radiation treatment of benign gynaecological disorders. A study of a cohort of metropathia patients. Acta. Oncol. 1990;29:563-7.
21. Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J. Natl. Cancer. Inst. 2005;97:1354-65.
22. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J Radiat. Oncol. Biol. Phys. 2003;56:83-8.
23. Epstein BE, Hanks GE. Radiation therapy techniques and dose selection in the treatment of prostate cancer. Semin. Radiat. Oncol. 1993;3:179-86.
24. Pisansky TM. External-beam radiotherapy for localized prostate cancer. N Engl. J Med. 2006;355:1583-91.